Recombinant AAT innovation creating infrastructure — biotechnology-derived alpha-1 antitrypsin enabling scalable sustainable enzyme production supporting expanded patient access and improved affordability, with the Human Alpha-1 Proteinase Inhibitor Market positioned for expansion where recombinant manufacturing enables broader treatment availability. Transgenic animal production through...